Kellanova (NYSE: K) Stock Competitors & Peer Comparison

Kellanova (NYSE: K) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, K stands at 29B. In comparison, MDLZ has a market cap of 81.4B. Regarding current trading prices, K is priced at $83.44 on the NYSE, while MDLZ trades at $63.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

K currently has a P/E ratio of 22.80, whereas MDLZ's P/E ratio is 22.39. In terms of profitability, K's ROE is +0.15%, compared to MDLZ's ROE of +0.13%. Regarding short-term risk, K is less volatile compared to MDLZ. This indicates lower risk in terms of short-term price fluctuations for K.Check MDLZ's competition here

Kellanova (NYSE: K) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, K stands at 29B. In comparison, HSY has a market cap of 34.1B. Regarding current trading prices, K is priced at $83.44 on the NYSE, while HSY trades at $169.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

K currently has a P/E ratio of 22.80, whereas HSY's P/E ratio is 23.37. In terms of profitability, K's ROE is +0.15%, compared to HSY's ROE of +0.32%. Regarding short-term risk, K is less volatile compared to HSY. This indicates lower risk in terms of short-term price fluctuations for K.Check HSY's competition here

Kellanova (NYSE: K) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, K stands at 29B. In comparison, TR has a market cap of 2.6B. Regarding current trading prices, K is priced at $83.44 on the NYSE, while TR trades at $34.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

K currently has a P/E ratio of 22.80, whereas TR's P/E ratio is 25.57. In terms of profitability, K's ROE is +0.15%, compared to TR's ROE of +0.10%. Regarding short-term risk, K is less volatile compared to TR. This indicates lower risk in terms of short-term price fluctuations for K.Check TR's competition here

Kellanova (NYSE: K) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, K stands at 29B. In comparison, SOWG has a market cap of 38.1M. Regarding current trading prices, K is priced at $83.44 on the NYSE, while SOWG trades at $1.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

K currently has a P/E ratio of 22.80, whereas SOWG's P/E ratio is -0.99. In terms of profitability, K's ROE is +0.15%, compared to SOWG's ROE of -16.52%. Regarding short-term risk, K is less volatile compared to SOWG. This indicates lower risk in terms of short-term price fluctuations for K.Check SOWG's competition here

Kellanova (NYSE: K) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, K stands at 29B. In comparison, RMCF has a market cap of 8.3M. Regarding current trading prices, K is priced at $83.44 on the NYSE, while RMCF trades at $0.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

K currently has a P/E ratio of 22.80, whereas RMCF's P/E ratio is -1.44. In terms of profitability, K's ROE is +0.15%, compared to RMCF's ROE of -1.31%. Regarding short-term risk, K is less volatile compared to RMCF. This indicates lower risk in terms of short-term price fluctuations for K.Check RMCF's competition here

Kellanova (NYSE: K) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, K stands at 29B. In comparison, CHSN has a market cap of 2.3M. Regarding current trading prices, K is priced at $83.44 on the NYSE, while CHSN trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

K currently has a P/E ratio of 22.80, whereas CHSN's P/E ratio is 0.31. In terms of profitability, K's ROE is +0.15%, compared to CHSN's ROE of +0.03%. Regarding short-term risk, K is less volatile compared to CHSN. This indicates lower risk in terms of short-term price fluctuations for K.Check CHSN's competition here